Key Highlights
- Q3 net revenue reached an all-time high of $206.7M, representing an 11% year-over-year increase and surpassing analyst projections of $201.35M
- The company delivered an unexpected adjusted EPS profit of $0.02, dramatically outperforming Wall Street’s forecasted loss of -$0.14
- Cannabis segment revenue climbed 19% to $64.8M, fueled by a remarkable 73% increase in international cannabis sales
- Adjusted EBITDA expanded 19% to reach $10.7M; management maintained fiscal 2026 guidance of $62M–$72M
- The company completed BrewDog acquisition for approximately £40M and established a strategic Carlsberg collaboration launching in 2027
Tilray Brands delivered exceptional third-quarter results for fiscal 2026, achieving record net revenue of $206.7 million. This represents a significant 11% increase compared to $185.8 million during the corresponding period last year, exceeding analyst expectations.
The most notable aspect was the earnings performance. Market analysts had projected a loss of 14 cents per share. Instead, Tilray reported an adjusted profit of $0.02 per share. This substantial earnings beat triggered immediate market reaction, with TLRY shares climbing 8.01%.
The company’s net loss totaled $25.2 million for the quarter. While this appears concerning at first glance, it represents a dramatic turnaround from the staggering $793.5 million loss recorded in the prior-year quarter.
Gross profit reached $55.0 million, reflecting a 6% year-over-year gain, while the consolidated gross margin stood at 27%.
The cannabis division delivered impressive results. Overall cannabis revenue expanded 19% to $64.8 million. International cannabis net revenue skyrocketed 73%, while cannabis flower sales volume doubled compared to last year.
In the Canadian market, adult-use and medical cannabis net revenue increased 8%, solidifying Tilray’s position as the leading cannabis revenue generator in Canada.
The distribution business also posted strong performance. It achieved a quarterly record of $83.0 million in net revenue, with distribution gross profit advancing to $10.0 million and margin expanding to 12%.
Tilray successfully completed its Project 420 synergy initiative during the quarter. This program generated approximately $33 million in annualized cost reductions.
Strategic BrewDog Acquisition and Carlsberg Alliance
Following the quarter’s conclusion, Tilray finalized its acquisition of BrewDog, the prominent UK craft beer brand, for roughly £40 million in cash. CEO Irwin Simon stated the transaction enables the company to develop a “scaled global beverage platform.”
Additionally, Tilray unveiled a strategic alliance with Carlsberg, scheduled to commence in 2027. According to the company, this partnership broadens its footprint across Europe, the Middle East, Australia, Asia-Pacific, and the United States.
Adjusted EBITDA for the third quarter totaled $10.7 million, marking a 19% improvement from $9.0 million in the year-ago period.
Management Maintains Fiscal Outlook
Executives reaffirmed their fiscal 2026 adjusted EBITDA guidance at $62 million to $72 million. This projection represents growth of 13% to 31% versus fiscal year 2025 results.
Wall Street’s consensus rating on TLRY currently stands at Hold, supported by one Buy recommendation and five Hold ratings issued within the last three months. The average analyst price target is $8.97, suggesting potential upside of approximately 38.64% from current trading levels.
Notwithstanding the strong Q3 performance, TLRY shares remain down 28.35% year-to-date and have declined 0.68% over the trailing 12-month period.
